Skip to main content
TipRanks
Go Ultimate75% OFF

Softmax Co., Ltd. (Japan) (3671) AI Stock Analysis

1 Followers
JP:3671

Softmax Co., Ltd. (Japan)

(TSE/TYO:3671)

Select Model
Rating:57Neutral
Price Target:JPY 240.00â–²(3.45% Upside)
Action:reiterated
Date:11/07/26

Softmax earns a middling score. Fundamentals are stable but deteriorating at the margin: the company stays profitable with excellent cash conversion and a growing equity base, yet a 22% revenue decline, margin compression, a 41% drop in operating cash flow and a near-doubling of debt point to a transitional and less certain period. Technicals compound the caution, with the price trading below every major moving average and momentum indicators (negative MACD, RSI near 20) confirming a sustained downtrend. Offsetting these risks, the valuation is attractive at a 12.2x P/E with a 3.64% dividend yield, offering a cushion if revenue stabilizes. Investors should watch for evidence that sales have bottomed and that the added leverage is being deployed productively before the outlook improves.

Positive Factors
Sustained ProfitabilityThe company has maintained positive and relatively stable profitability across several years, indicating an established operating model and ongoing ability to convert its services into earnings. This provides a durable base for reinvestment and resilience even as recent growth has weakened.
Negative Factors
Revenue ContractionThe sharp 2025 revenue decline represents a material weakening in demand or project activity compared with the preceding growth period. If the contraction persists, it could reduce operating leverage, constrain investment capacity, and make restoring prior earnings momentum more difficult.

Softmax Co., Ltd. (Japan) (3671) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%JP:3671-26.82%EWJ+6.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 5.58B
Dividend Yield
4.31%
Average Volume (3M)
23.91K
Price to Earnings (P/E)
11.4
Beta (1Y)
0.63
Revenue Growth
-4.63%
EPS Growth
-28.26%
Country
Japan
Employees
230
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Softmax Co., Ltd. (Japan) Business Overview & Revenue Model

Company Description

Softmax Co., Ltd handles the complete spectrum of corporate system services, encompassing their development, commercialization, deployment, and ongoing support. A significant portion of their work is dedicated to creating advanced medical information...

Softmax Co., Ltd. (Japan) Financial Statement Overview

Summary

Blended view of the Income Statement (62), Balance Sheet (58) and Cash Flow (55) scores. Softmax remains consistently profitable with net income rising to ¥573 million and net margins steady at 8-9%, supported by near-perfect free cash flow conversion (99% of net income) and a light capex model. However, the trajectory has weakened: revenue fell 22% in FY2025, breaking a multi-year growth trend; gross margin compressed from 30.8% to 26.9%; operating cash flow dropped 41% to ¥389 million; and total debt nearly doubled to ¥2.5 billion, lifting debt-to-equity to 0.63 from 0.40. The growing equity base (¥3.9 billion) and historically solid ROE (13-16%) keep the profile sound, but the combination of shrinking revenue, weaker cash generation and rising leverage caps the score near the middle of the range.

Income Statement

62Positive

Balance Sheet

58Neutral

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.92B6.93B5.43B5.26B5.05B4.49B
Gross Profit1.82B1.86B1.66B1.55B1.43B1.44B
EBITDA693.86M784.12M702.47M621.88M571.83M612.45M
Net Income488.18M573.46M480.15M452.77M419.39M422.55M
Balance Sheet
Total Assets8.63B9.13B7.54B6.72B6.55B5.76B
Cash, Cash Equivalents and Short-Term Investments2.71B3.12B3.45B2.92B2.85B2.76B
Total Debt2.21B2.48B1.41B1.33B1.35B1.38B
Total Liabilities4.64B5.20B4.02B3.50B3.61B3.14B
Stockholders Equity3.99B3.93B3.52B3.22B2.94B2.62B
Cash Flow
Free Cash Flow0384.89M625.84M215.28M163.96M266.65M
Operating Cash Flow0388.95M663.98M232.54M179.73M284.30M
Investing Cash Flow0-1.17B-92.76M-11.61M-4.75M-1.01M
Financing Cash Flow0883.56M-100.22M-200.04M-144.93M-401.85M

Softmax Co., Ltd. (Japan) Technical Analysis

Technical Analysis SentimentNegative
Last Price232.00

Price Trends

50DMA291.70Negative
100DMA302.14Negative
200DMA312.28Negative

Market Momentum

MACD-14.34Positive
RSI19.20Positive
STOCH0.68Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3671, the sentiment is Negative. The current price of 232.00 is below the 20-day moving average (MA) of 267.50, below the 50-day MA of 291.70, and below the 200-day MA of 312.28, indicating a bearish trend. The MACD of -14.34 indicates Positive momentum. The RSI at 19.20 is Positive, neither overbought nor oversold. The STOCH value of 0.68 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3671.

Softmax Co., Ltd. (Japan) Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:3671 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4483JP:448372OutperformJPY 232.67B30.67―0.52%20.50%19.27%
JP:4480JP:448058NeutralJPY 56.52B32.4911.30%―21.01%10.15%
JP:3671JP:367157NeutralJPY 5.84B11.43―4.31%-4.63%-28.26%
JP:4438JP:443854NeutralJPY 2.16B-4.75――34.13%35.54%
JP:9341JP:934153NeutralJPY 10.04B14.86―5.41%46.39%12.53%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%40%JP:3671JP:4480JP:4438JP:4483JP:9341Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:3671 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3671Softmax Co., Ltd. (Japan)232.00-85.02-26.82%
JP:4480Medley, Inc.1780.00-870.00-32.83%
JP:4438Welby Inc.257.00-38.00-12.88%
JP:4483JMDC Inc.3440.00-759.57-18.09%
JP:9341GENOVA Inc.555.00-7.50-1.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026